» Articles » PMID: 16858390

Glial Inhibition of CNS Axon Regeneration

Overview
Specialty Neurology
Date 2006 Jul 22
PMID 16858390
Citations 688
Authors
Affiliations
Soon will be listed here.
Abstract

Damage to the adult CNS often leads to persistent deficits due to the inability of mature axons to regenerate after injury. Mounting evidence suggests that the glial environment of the adult CNS, which includes inhibitory molecules in CNS myelin as well as proteoglycans associated with astroglial scarring, might present a major hurdle for successful axon regeneration. Here, we evaluate the molecular basis of these inhibitory influences and their contributions to the limitation of long-distance axon repair and other types of structural plasticity. Greater insight into glial inhibition is crucial for developing therapies to promote functional recovery after neural injury.

Citing Articles

Human dental pulp stem cells for spinal cord injury.

Wang K, Liu X, Jiang X, Chen S, Wang H, Wang Z Stem Cell Res Ther. 2025; 16(1):123.

PMID: 40055766 PMC: 11887269. DOI: 10.1186/s13287-025-04244-2.


Validation of qMT and CEST MRI as Biomarkers of Response to Treatment After Lumbar Spinal Cord Injury in Rats.

Mu C, Reed J, Wang F, Yan X, Lu M, Gore J NMR Biomed. 2025; 38(4):e70015.

PMID: 40040273 PMC: 11880742. DOI: 10.1002/nbm.70015.


Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.

Zhang X, Yang C, Zhang C, Wu J, Zhang X, Gao J Nat Commun. 2025; 16(1):2174.

PMID: 40038284 PMC: 11880380. DOI: 10.1038/s41467-025-57445-x.


Multiplexed CRISPRi Reveals a Transcriptional Switch Between KLF Activators and Repressors in the Maturing Neocortex.

Kirk R, Sun L, Xiao R, Clark E, Nelson S bioRxiv. 2025; .

PMID: 39975013 PMC: 11839100. DOI: 10.1101/2025.02.07.636951.


The potential role of RhoA/ROCK-inhibition on locomotor recovery after spinal cord injury: a systematic review of in-vivo studies.

Khavandegar A, Ahmadi N, Mousavi M, Ramezani Z, Khodadoust E, Hasan Zadeh Tabatabaei M Spinal Cord. 2025; 63(3):95-126.

PMID: 39956860 DOI: 10.1038/s41393-025-01064-2.


References
1.
Venkatesh K, Chivatakarn O, Lee H, Joshi P, Kantor D, Newman B . The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J Neurosci. 2005; 25(4):808-22. PMC: 6725623. DOI: 10.1523/JNEUROSCI.4464-04.2005. View

2.
He Z, Koprivica V . The Nogo signaling pathway for regeneration block. Annu Rev Neurosci. 2004; 27:341-68. DOI: 10.1146/annurev.neuro.27.070203.144340. View

3.
Lee J, Kim J, Sivula M, Strittmatter S . Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci. 2004; 24(27):6209-17. PMC: 6729662. DOI: 10.1523/JNEUROSCI.1643-04.2004. View

4.
Tom V, Steinmetz M, Miller J, Doller C, Silver J . Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci. 2004; 24(29):6531-9. PMC: 6729861. DOI: 10.1523/JNEUROSCI.0994-04.2004. View

5.
Hasegawa Y, Fujitani M, Hata K, Tohyama M, Yamagishi S, Yamashita T . Promotion of axon regeneration by myelin-associated glycoprotein and Nogo through divergent signals downstream of Gi/G. J Neurosci. 2004; 24(30):6826-32. PMC: 6729720. DOI: 10.1523/JNEUROSCI.1856-04.2004. View